{"status": "Ok", "redirect_url": "https://www.prnewswire.com//news-releases/ptc-therapeutics-announces-new-sephience-sepiapterin-data-reinforcing-broad-patient-benefits-including-sustained-metabolic-control-and-diet-liberalization-as-well-as-consistent-favorable-safety-profile-302857832.html", "message": "News view counter 898602 successfully enlarged"}